3.3.1.900 html 139 232 1 false 43 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.immunomedics.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.immunomedics.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.immunomedics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.immunomedics.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.immunomedics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 10101 - Disclosure - Business Overview and Basis of Presentation Sheet http://www.immunomedics.com/role/DisclosureBusinessOverviewAndBasisOfPresentation Business Overview and Basis of Presentation Notes 6 false false R7.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.immunomedics.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 10301 - Disclosure - Marketable Securities Sheet http://www.immunomedics.com/role/DisclosureMarketableSecurities Marketable Securities Notes 8 false false R9.htm 10401 - Disclosure - Convertible Senior Notes Notes http://www.immunomedics.com/role/DisclosureConvertibleSeniorNotes Convertible Senior Notes Notes 9 false false R10.htm 10501 - Disclosure - Estimated Fair Value of Financial Instruments Sheet http://www.immunomedics.com/role/DisclosureEstimatedFairValueOfFinancialInstruments Estimated Fair Value of Financial Instruments Notes 10 false false R11.htm 10601 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.immunomedics.com/role/DisclosureAccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 11 false false R12.htm 10701 - Disclosure - Stock Incentive Plan Sheet http://www.immunomedics.com/role/DisclosureStockIncentivePlan Stock Incentive Plan Notes 12 false false R13.htm 10801 - Disclosure - Geographic Segments Sheet http://www.immunomedics.com/role/DisclosureGeographicSegments Geographic Segments Notes 13 false false R14.htm 10901 - Disclosure - Related Party Transactions Sheet http://www.immunomedics.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 11001 - Disclosure - License and Collaboration Agreements Sheet http://www.immunomedics.com/role/DisclosureLicenseAndCollaborationAgreements License and Collaboration Agreements Notes 15 false false R16.htm 11101 - Disclosure - Commitments and Contingencies Sheet http://www.immunomedics.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 11201 - Disclosure - Subsequent Events Sheet http://www.immunomedics.com/role/DisclosureSubsequentEvents Subsequent Events Notes 17 false false R18.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.immunomedics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.immunomedics.com/role/DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.immunomedics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.immunomedics.com/role/DisclosureSummaryOfSignificantAccountingPolicies 19 false false R20.htm 30303 - Disclosure - Marketable Securities (Tables) Sheet http://www.immunomedics.com/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.immunomedics.com/role/DisclosureMarketableSecurities 20 false false R21.htm 30503 - Disclosure - Estimated Fair Value of Financial Instruments (Tables) Sheet http://www.immunomedics.com/role/DisclosureEstimatedFairValueOfFinancialInstrumentsTables Estimated Fair Value of Financial Instruments (Tables) Tables http://www.immunomedics.com/role/DisclosureEstimatedFairValueOfFinancialInstruments 21 false false R22.htm 30603 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.immunomedics.com/role/DisclosureAccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.immunomedics.com/role/DisclosureAccumulatedOtherComprehensiveLoss 22 false false R23.htm 30703 - Disclosure - Stock Incentive Plan (Tables) Sheet http://www.immunomedics.com/role/DisclosureStockIncentivePlanTables Stock Incentive Plan (Tables) Tables http://www.immunomedics.com/role/DisclosureStockIncentivePlan 23 false false R24.htm 30803 - Disclosure - Geographic Segments (Tables) Sheet http://www.immunomedics.com/role/DisclosureGeographicSegmentsTables Geographic Segments (Tables) Tables http://www.immunomedics.com/role/DisclosureGeographicSegments 24 false false R25.htm 40101 - Disclosure - Business Overview and Basis of Presentation - Narratives (Details) Sheet http://www.immunomedics.com/role/DisclosureBusinessOverviewAndBasisOfPresentationNarrativesDetails Business Overview and Basis of Presentation - Narratives (Details) Details 25 false false R26.htm 40201 - Disclosure - Summary of Significant Accounting Policies - Income Tax and Net Loss Per share (Detais) Sheet http://www.immunomedics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxAndNetLossPerShareDetais Summary of Significant Accounting Policies - Income Tax and Net Loss Per share (Detais) Uncategorized 26 false false R27.htm 40202 - Disclosure - Summary of Significant Accounting Policies - Schedule of Options Weighted-Average Assumptions (Details) Sheet http://www.immunomedics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfOptionsWeightedAverageAssumptionsDetails Summary of Significant Accounting Policies - Schedule of Options Weighted-Average Assumptions (Details) Uncategorized 27 false false R28.htm 40301 - Disclosure - Marketable Securities - Components of Marketable Securities (Details) Sheet http://www.immunomedics.com/role/DisclosureMarketableSecuritiesComponentsOfMarketableSecuritiesDetails Marketable Securities - Components of Marketable Securities (Details) Uncategorized 28 false false R29.htm 40302 - Disclosure - Marketable Securities - Maturities of Debt Securities Classified as Available-for-Sale (Details) Sheet http://www.immunomedics.com/role/DisclosureMarketableSecuritiesMaturitiesOfDebtSecuritiesClassifiedAsAvailableForSaleDetails Marketable Securities - Maturities of Debt Securities Classified as Available-for-Sale (Details) Uncategorized 29 false false R30.htm 40401 - Disclosure - Convertible Senior Notes - Narratives (Details) Notes http://www.immunomedics.com/role/DisclosureConvertibleSeniorNotesNarrativesDetails Convertible Senior Notes - Narratives (Details) Uncategorized 30 false false R31.htm 40501 - Disclosure - Estimated Fair Value of Financial Instruments - Cash equivalents and marketable securities (Details) Sheet http://www.immunomedics.com/role/DisclosureEstimatedFairValueOfFinancialInstrumentsCashEquivalentsAndMarketableSecuritiesDetails Estimated Fair Value of Financial Instruments - Cash equivalents and marketable securities (Details) Uncategorized 31 false false R32.htm 40502 - Disclosure - Estimated Fair Value of Financial Instruments - Schedule of Carrying Amounts and Estimated Fair Values (Level 2) of Debt Instruments (Details) Sheet http://www.immunomedics.com/role/DisclosureEstimatedFairValueOfFinancialInstrumentsScheduleOfCarryingAmountsAndEstimatedFairValuesLevel2OfDebtInstrumentsDetails Estimated Fair Value of Financial Instruments - Schedule of Carrying Amounts and Estimated Fair Values (Level 2) of Debt Instruments (Details) Uncategorized 32 false false R33.htm 40601 - Disclosure - Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Loss (Details) Sheet http://www.immunomedics.com/role/DisclosureAccumulatedOtherComprehensiveLossComponentsOfAccumulatedOtherComprehensiveLossDetails Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Loss (Details) Uncategorized 33 false false R34.htm 40602 - Disclosure - Accumulated Other Comprehensive Loss - Narratives (Details) Sheet http://www.immunomedics.com/role/DisclosureAccumulatedOtherComprehensiveLossNarrativesDetails Accumulated Other Comprehensive Loss - Narratives (Details) Uncategorized 34 false false R35.htm 40701 - Disclosure - Stock Incentive Plan -Narratives (Details) Sheet http://www.immunomedics.com/role/DisclosureStockIncentivePlanNarrativesDetailss Stock Incentive Plan -Narratives (Details) Uncategorized 35 false false R36.htm 40702 - Disclosure - Stock Incentive Plan - Summary of Options (Details) Sheet http://www.immunomedics.com/role/DisclosureStockIncentivePlanSummaryOfOptionsDetails Stock Incentive Plan - Summary of Options (Details) Uncategorized 36 false false R37.htm 40703 - Disclosure - Stock Incentive Plan - Non-Vested Restricted and Performance Stock Units (Details) Sheet http://www.immunomedics.com/role/DisclosureStockIncentivePlanNonVestedRestrictedAndPerformanceStockUnitsDetails Stock Incentive Plan - Non-Vested Restricted and Performance Stock Units (Details) Uncategorized 37 false false R38.htm 40704 - Disclosure - Stock Incentive Plan - Narratives (Details) Sheet http://www.immunomedics.com/role/DisclosureStockIncentivePlanNarrativesDetails Stock Incentive Plan - Narratives (Details) Uncategorized 38 false false R39.htm 40801 - Disclosure - Geographic Segments - Financial Information Based on Geographic Location of Facilities (Details) Sheet http://www.immunomedics.com/role/DisclosureGeographicSegmentsFinancialInformationBasedOnGeographicLocationOfFacilitiesDetails Geographic Segments - Financial Information Based on Geographic Location of Facilities (Details) Uncategorized 39 false false R40.htm 40901 - Disclosure - Related Party Transactions - Narratives (Details) Sheet http://www.immunomedics.com/role/DisclosureRelatedPartyTransactionsNarrativesDetails Related Party Transactions - Narratives (Details) Uncategorized 40 false false R41.htm 41001 - Disclosure - License and Collaboration Agreements - Narratives (Details) Sheet http://www.immunomedics.com/role/DisclosureLicenseAndCollaborationAgreementsNarrativesDetails License and Collaboration Agreements - Narratives (Details) Uncategorized 41 false false R42.htm 41101 - Disclosure - Commitments and Contingencies - Narratives (Details) Sheet http://www.immunomedics.com/role/DisclosureCommitmentsAndContingenciesNarrativesDetails Commitments and Contingencies - Narratives (Details) Uncategorized 42 false false R43.htm 41201 - Disclosure - Subsequent Events (Details) Sheet http://www.immunomedics.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Uncategorized 43 false false All Reports Book All Reports immu-20151231.xml immu-20151231.xsd immu-20151231_cal.xml immu-20151231_def.xml immu-20151231_lab.xml immu-20151231_pre.xml true true